Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1318-20. doi: 10.1158/1055-9965.EPI-07-0084.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Arylsulfotransferase / genetics
  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / genetics*
  • Catechol O-Methyltransferase / genetics
  • Cytochrome P-450 Enzyme System / genetics
  • Estrogen Replacement Therapy / adverse effects*
  • Estrogens / adverse effects
  • Estrogens / genetics*
  • Estrogens / metabolism*
  • Female
  • Humans
  • Middle Aged
  • Progestins / adverse effects
  • Progestins / metabolism

Substances

  • Estrogens
  • Progestins
  • Cytochrome P-450 Enzyme System
  • Catechol O-Methyltransferase
  • Arylsulfotransferase
  • SULT1A1 protein, human